The results showed that the expression of NF-κB and p-NF-κB protein in the model group was higher than that in the control group, and the positive and treatment groups decreased the expression of NF-κB and p-NF-κB protein at Day 28 after BLM-induced IPF. The gene discussed is NFKB1; the disease is idiopathic pulmonary fibrosis.